XML 66 R52.htm IDEA: XBRL DOCUMENT v3.20.2
Capital Stock and Share-Based Compensation - Equity Transactions (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2020
Mar. 31, 2020
Jun. 30, 2019
Mar. 31, 2019
Jun. 30, 2020
Jun. 30, 2019
Increase (Decrease) in Stockholders' Equity            
Stockholder's equity beginning balance $ 67,777 $ 67,469 $ 64,008 $ 62,354 $ 67,469 $ 62,354
Exercise of stock options (in shares)         662,965  
Exercise of stock options 726 1,198 182 185    
Share-based compensation 465 502 378 343    
Deferred compensation issuance 78          
Stock dividends to Carilion Clinic     0 0    
Net income 1,369 (1,116) 841 1,126 $ 253 1,967
Forfeitures of restricted stock (410) (276)        
Purchase of treasury stock (204)   (220)      
Stockholder's equity ending balance $ 69,801 $ 67,777 $ 65,189 $ 64,008 $ 69,801 $ 65,189
Preferred Stock            
Increase (Decrease) in Stockholders' Equity            
Beginning balance (in shares) 0 0 1,321,514 1,321,514 0 1,321,514
Stockholder's equity beginning balance $ 0 $ 0 $ 1 $ 1 $ 0 $ 1
Ending balance (in shares) 0 0 1,321,514 1,321,514 0 1,321,514
Stockholder's equity ending balance $ 0 $ 0 $ 1 $ 1 $ 0 $ 1
Common Stock            
Increase (Decrease) in Stockholders' Equity            
Beginning balance (in shares) 30,486,577 30,149,105 28,145,713 27,956,401 30,149,105 27,956,401
Stockholder's equity beginning balance $ 32 $ 32 $ 30 $ 30 $ 32 $ 30
Exercise of stock options (in shares) 346,461 316,504 207,786 189,312    
Share-based compensation (in shares) 11,600 55,668        
Deferred compensation issuance (in shares) 47,377          
Forfeitures of restricted stock (in shares) (61,530) (34,700)        
Purchase of treasury stock (in shares) (32,950)   (52,733)      
Ending balance (in shares) 30,797,535 30,486,577 28,300,766 28,145,713 30,797,535 28,300,766
Stockholder's equity ending balance $ 32 $ 32 $ 30 $ 30 $ 32 $ 30
Treasury Stock            
Increase (Decrease) in Stockholders' Equity            
Beginning balance (in shares) 1,639,791 1,639,791 1,253,105 1,253,105 1,639,791 1,253,105
Stockholder's equity beginning balance $ (4,337) $ (4,337) $ (2,117) $ (2,117) $ (4,337) $ (2,117)
Purchase of treasury stock (in shares) 32,950   52,733      
Purchase of treasury stock $ (204)   $ (220)      
Ending balance (in shares) 1,672,741 1,639,791 1,305,838 1,253,105 1,672,741 1,305,838
Stockholder's equity ending balance $ (4,541) $ (4,337) $ (2,337) $ (2,117) $ (4,541) $ (2,337)
Additional Paid-in Capital            
Increase (Decrease) in Stockholders' Equity            
Stockholder's equity beginning balance 89,446 88,022 86,356 85,745 88,022 85,745
Exercise of stock options 726 1,198 182 185    
Share-based compensation 465 501 378 343    
Deferred compensation issuance 78          
Stock dividends to Carilion Clinic     90 83    
Forfeitures of restricted stock (410) (275)        
Stockholder's equity ending balance 90,305 89,446 87,006 86,356 90,305 87,006
Accumulated Deficit            
Increase (Decrease) in Stockholders' Equity            
Stockholder's equity beginning balance (17,364) (16,248) (20,262) (21,305) (16,248) (21,305)
Stock dividends to Carilion Clinic     (90) (83)    
Net income 1,369 (1,116) 841 1,126    
Stockholder's equity ending balance $ (15,995) $ (17,364) $ (19,511) $ (20,262) $ (15,995) $ (19,511)